Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oliff

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Leukemia|November 1, 1987
Modulation of Friend virus infectivity in vivo by administration of purified preparations of human lactoferrin and recombinant murine interleukin-3 to miceG Hangoc, L Lu, A Oliff, et al.
Growth Factors (Chur, Switzerland)|January 1, 1989
Spontaneously transformed NRK cells lose their mitogenic response to epidermal growth factorR J Wegrzyn, D Defeo-Jones, D C Heimbrook, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptorS H Socher, M W Riemen, D Martinez, et al.
Cell|August 14, 1987
Tumors secreting human TNF/cachectin induce cachexia in miceA Oliff, D Defeo-Jones, M Boyer, et al.
The Journal of Biological Chemistry|May 25, 1988
Minimal ligand analysis of gastrin releasing peptide. Receptor binding and mitogenesisD C Heimbrook, M E Boyer, V M Garsky, et al.
Molecular and Cellular Biology|April 1, 1991
Lovastatin selectively inhibits ras activation of the 12-O-tetradecanoylphorbol-13-acetate response element in mammalian cellsD Defeo-Jones, E M McAvoy, R E Jones, et al.
Peptides|September 1, 1987
Isolation of multiple biologically and chemically diverse species of epidermal growth factorM W Riemen, R J Wegrzyn, A E Baker, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Cloning and mutagenesis of the p110 alpha subunit of human phosphoinositide 3'-hydroxykinaseS M Stirdivant, J Ahern, R R Conroy, et al.
Molecular and Cellular Biology|September 1, 1989
Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bondsD Defeo-Jones, J Y Tai, G A Vuocolo, et al.
Current Opinion in Chemical Biology|August 1, 1997
Farnesyltransferase inhibitors versus Ras inhibitorsJ B Gibbs, S L Graham, G D Hartman, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Leukemia|November 1, 1987
Modulation of Friend virus infectivity in vivo by administration of purified preparations of human lactoferrin and recombinant murine interleukin-3 to miceG Hangoc, L Lu, A Oliff, et al.
Growth Factors (Chur, Switzerland)|January 1, 1989
Spontaneously transformed NRK cells lose their mitogenic response to epidermal growth factorR J Wegrzyn, D Defeo-Jones, D C Heimbrook, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptorS H Socher, M W Riemen, D Martinez, et al.
Cell|August 14, 1987
Tumors secreting human TNF/cachectin induce cachexia in miceA Oliff, D Defeo-Jones, M Boyer, et al.
The Journal of Biological Chemistry|May 25, 1988
Minimal ligand analysis of gastrin releasing peptide. Receptor binding and mitogenesisD C Heimbrook, M E Boyer, V M Garsky, et al.
Molecular and Cellular Biology|April 1, 1991
Lovastatin selectively inhibits ras activation of the 12-O-tetradecanoylphorbol-13-acetate response element in mammalian cellsD Defeo-Jones, E M McAvoy, R E Jones, et al.
Peptides|September 1, 1987
Isolation of multiple biologically and chemically diverse species of epidermal growth factorM W Riemen, R J Wegrzyn, A E Baker, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Cloning and mutagenesis of the p110 alpha subunit of human phosphoinositide 3'-hydroxykinaseS M Stirdivant, J Ahern, R R Conroy, et al.
Molecular and Cellular Biology|September 1, 1989
Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bondsD Defeo-Jones, J Y Tai, G A Vuocolo, et al.
Current Opinion in Chemical Biology|August 1, 1997
Farnesyltransferase inhibitors versus Ras inhibitorsJ B Gibbs, S L Graham, G D Hartman, et al.
Pageof 9